ClinicalTrials.gov
public full text
Public Domain
Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
To investigate that the efficacy of 3% DE-089 ophthalmic solution (one drop at a time, 6 times daily, 4 weeks topical administration), in comparison to 0.1% sodium hyaluronate ophthalmic solution (0.1% HA) (one drop at a time, 6 times daily, 4 weeks topical administration), is at least non-inferior in the change in fluorescein staining score, and is superior in the change in Rose bengal score, in a multicenter, double-masked, parallel-group comparison study. Safety profile will likewise be compared.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests#891950
- Management of Dry Eye Disease After Cataract Surgery With Topical Hyaluronic Acid and Gingko Biloba#1093752
- Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease.#1152278
- Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease#1030025
- Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease#864886
Record · ID 1230001
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive